Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Histopathology|July 26, 2022
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancerAyaka Katayama, Jane Starczynski, Michael S Toss, et al.Histopathology|March 5, 2024
A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR)Veerle Bossuyt, Elena Provenzano, W Fraser Symmans, et al.The FEBS Journal|June 23, 2015
Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patientsFiona Lanigan, Gerard L Brien, Yue Fan, et al.British Journal of Cancer|March 25, 2021
Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) casesEmad A Rakha, Islam M Miligy, Cecily M Quinn, et al.Current Oncology (Toronto, Ont.)|March 27, 2024
Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in IrelandLynda M McSorley, Mehala Tharmabala, Fathiya Al Rahbi, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancerAyaka Katayama, Islam M Miligy, Sho Shiino, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 24, 2026
A Worldwide Survey on Pathological Measurement of Residual Breast Cancer After Neoadjuvant Therapy: Different Interpretations of the ypTNM ClassificationKoen Kwakkenbos, Mieke R Van Bockstal, Abeer M Shaaban, et al.Pageof 4